Our Mission
We are committed to improving outcomes for everyone, everywhere, affected by gynecologic cancer.
The Gynecologic Cancer InterGroup (GCIG) is a global network that brings together research groups dedicated to clinical trials in gynecologic cancers. We have a strong track record of successful collaboration on phase III trials, consensus conferences, educational events, and scholarly publications.
Our Strategic Goals
Improved Outcomes
Promoting Research Excellence
Building the Next Generation
Collaborating with Partners
Enhancing Sustainability
Improving Equity, Diversity & Inclusivity
Our Impact
Member Groups
Clinical Trials
Year Founded
Publications
Pragmatic Trials: Advancing Real-World Impact
GCIG is committed to championing pragmatic clinical trials that are designed to reflect the complexities of everyday clinical practice. Unlike highly controlled traditional trials, pragmatic trials focus on real-world populations, diverse care settings, and outcomes that matter to both patients and clinicians. This approach helps ensure that the evidence we generate is not only scientifically robust but also directly applicable across global healthcare systems.
Why Pragmatic Trials Matter
Answer Real-World Questions
Pragmatic trials are designed to address the everyday clinical dilemmas faced in multidisciplinary team (MDT) meetings.
Include Broader Patient Groups
These trials reduce exclusions and better reflect the diversity of patients seen in routine clinical care.
Enable Cost-Efficient, Feasible Research
By integrating into existing workflows, pragmatic trials are more scalable across a range of healthcare settings.
Accelerate Impact and Practice Change
They improve external validity and generate insights that can directly inform real-world decision-making.
Upcoming Meetings
Our Membership
The Gynecologic Cancer Intergroup (GCIG) is an international organization with membership that currently includes 33 GCIG Cooperative Group Members, 8 Liaison Members, 8 Pharma/Biotech Partners and 1 Regulatory/National Authority Member.
Becoming a Member
Any international or national research cooperative group performing clinical trials in gynecologic cancer may become a member group of the GCIG. A cooperative group consists of several centers hence a single center is not eligible for membership.
Meet the Executive Team
The GCIG Executive Team is composed of the current GCIG Chair, the Immediate Past Chair, and the Chair-Elect, who collectively lead the GCIG Board of Directors and Executive Committee during their respective terms. Each role has a two-year term.
Michael Bookman
GCIG Chair (Dec 2024)
Christian Marth
GCIG Chair-Elect
Alison Brand
Past GCIG Chair
